טוען...
Oritavancin Diphosphate
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on ag...
שמור ב:
| הוצא לאור ב: | Hosp Pharm |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Thomas Land Publishers, Inc.
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319806/ https://ncbi.nlm.nih.gov/pubmed/25673895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hjp4911-1049 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|